Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Diagnostic Medical Systems's Enterprise Value is €44.45 Mil.
Diagnostic Medical Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-1.87 Mil. Therefore, Diagnostic Medical Systems's EV-to-EBIT ratio for today is -23.76.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Diagnostic Medical Systems (XPAR:ALDMS) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Diagnostic Medical Systems's EV-to-EBIT for today is
Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was €-1.87 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Diagnostic Medical Systems's EV-to-EBITDA for today is:
Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €0.70 Mil.
Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was €46.07 Mil.
Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €3.60 Mil.
Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Diagnostic Medical Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems Enterprise Value Related Terms
Diagnostic Medical Systems Enterprise Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALDMS vs ABT, SYK, MDT: Enterprise Value Comparison
For the Medical Devices subindustry, Diagnostic Medical Systems's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Diagnostic Medical Systems Enterprise Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Diagnostic Medical Systems's Enterprise Value falls into.
Diagnostic Medical Systems Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Diagnostic Medical Systems's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Diagnostic Medical Systems (XPAR:ALDMS) has a Enterprise Value of €44.45 Mil as of Jun. 30, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Diagnostic Medical Systems and its competitors.
Is Diagnostic Medical Systems' Enterprise Value too high?
Diagnostic Medical Systems' current Enterprise Value is €44.45 Mil. Overall, Diagnostic Medical Systems has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Enterprise Value compare to ABT and SYK?
Diagnostic Medical Systems' Enterprise Value of €44.45 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Devices & Instruments company?
A good Enterprise Value depends on the Medical Devices & Instruments industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Diagnostic Medical Systems and its competitors. Diagnostic Medical Systems's current Enterprise Value is €44.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.25 — trading 9.2% above its estimated fair value. The current Enterprise Value is €44.45 Mil. Diagnostic Medical Systems' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current Enterprise Value is €44.45 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?
Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued.
The current stock price of €1.25 is trading 9.2% above its estimated GF Value™ of €1.14.
GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.
Key valuation signals for XPAR:ALDMS:
Enterprise Value: €44.45 Mil
GF Value™: €1.14 vs. price of €1.25 (9.2% above fair value)
No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
68GF Score
Get the complete analysis for XPAR:ALDMS
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALDMS has been successfully added to your 
